UNSPSC 51281506: Aminosalicylic acid

This classification denotes an antitubercular agent with the molecular formula C7H7NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5B2658E0N2, chemically known as 6018-19-5 (monosodium, dihydrate) but generally known as aminosalicylic acid, which bears US NIH Compound Identifier 4649. European Medicines Agency schedules Aminosalicylic acid in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB12862MIG.

World Health Organization schedules aminosalicylic acid in its Anatomical Therapeutic Chemical (ATC) Classification. As of Q4 2014, AMINOSALICYLIC ACID remains the US FDA Preferred Term for this commodity. Aminosalicylic acid bears US NLM identifiers UMLS ID C0030125 and NCI Concept Code C47394. SMILES: Oc1c(ccc(N)c1)C(=O)O.

UNSPSC 51281506 Aminosalicylic acid is a Commodity code. State and local governments soliciting under this code are actually purchasing naloxone, drug deactivation systems, medical and first aid supplies, and generic multi-source pharmaceuticals and over-the-counter products — a significant mismatch between the code's nominal scope and the work being bought. The issuing bodies represent a diverse mix including county health departments, state health and human services agencies, municipal fire departments, and cooperative purchasing alliances serving multi-state jurisdictions. Recent opportunities show demand driven primarily by public health initiatives, emergency medical response programs, and state pharmacy benefit management, with procurement structured through competitive bidding (IFB), requests for proposals (RFP), and requests for information (RFI) mechanisms designed to aggregate demand across multiple jurisdictions or establish framework contracts for ongoing distribution.

Recent activity clusters in Florida, Texas, and Minnesota. Seminole County, Florida issued an IFB (60459723LAS) in June 2026 for 1,900 units of naloxone and 800 safe drug deactivation systems annually, with quarterly deliveries to the Seminole County Community Health Building and a response deadline of July 26, 2026. The Texas Health and Human Services Commission posted an RFI (HHS0017013) in April 2026 to gather vendor capabilities for a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program. The City of Tampa issued an IFB (26P00145) in March 2026 for 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division, with an estimated contract value of $700,000.00 and a small local business enterprise set-aside providing a 5 percent bid discount. The Minnesota Multistate Cooperative Purchasing Alliance released an RFP (S1070000015802) in January 2026 for generic multi-source pharmaceuticals and OTC products with a March 26, 2026 proposal deadline, establishing framework contracts effective July 1, 2026 for distribution through three authorized wholesalers serving Minnesota, Oregon, and other participating jurisdictions.